Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

meeting   publishing date : 2021 - 04 - 14    save search

CPS Technologies Corporation Announces Details For Its 2021 Annual Meeting of Stockholders
Published: 2021-04-14 (Crawled : 21:00) - globenewswire.com
CPSH | $1.77 -0.55% 1.6K twitter stocktwits trandingview |
Producer Manufacturing
| | O: 0.0% H: 0.0% C: -9.85%


NanoVibronix Adjourns Special Meeting of Stockholders
Published: 2021-04-14 (Crawled : 17:00) - globenewswire.com
NAOV 4 | $0.77 -5.68% 8.6K twitter stocktwits trandingview |
Health Technology
| | O: -0.68% H: 10.1% C: 6.74%


Yahoo Finance to Exclusively Livestream Berkshire Hathaway Shareholders Meeting
Published: 2021-04-14 (Crawled : 14:15) - globenewswire.com
VZ | News | $39.49 -0.53% 0.36% 16M twitter stocktwits trandingview |
Communications
| | O: -0.21% H: 1.1% C: 0.35%


Baozun Schedules 2021 Annual General Meeting of Shareholders
Published: 2021-04-14 (Crawled : 14:00) - globenewswire.com
BZUN | $2.655 4.12% 3.95% 400K twitter stocktwits trandingview |
Retail Trade
| | O: 0.66% H: 3.75% C: 0.74%


Results from TORM plc’s Annual General Meeting on 14 April 2021
Published: 2021-04-14 (Crawled : 14:00) - globenewswire.com
TRMD | $35.33 -1.4% -1.42% 850K twitter stocktwits trandingview |
Transportation
| | O: 1.17% H: 2.43% C: 2.43%

results
CORMEDIX HAS MEETING WITH FDA ON DEFENCATH CATHETER LOCK SOLUTION NDA
Published: 2021-04-14 (Crawled : 13:15) - cormedix.com
CRMD | $5.34 -2.02% -2.06% 420K twitter stocktwits trandingview |
Health Technology
| | O: 0.96% H: 0.0% C: -16.17%

fda
Jaguar Health and Napo Pharmaceuticals Announce Acceptance of Abstract for Poster Presentation at American Society of Clinical Oncology Annual Meeting
Published: 2021-04-14 (Crawled : 13:00) - biospace.com/
JAGX | News | $0.1704 1.43% 1.41% 34M twitter stocktwits trandingview |
Health Technology
| | O: -1.18% H: 1.8% C: 1.2%

presentation
I-Mab Announces Selected Poster Presentation of CD73 Antibody Uliledlimab at American Society of Clinical Oncology (ASCO) 2021 Annual Meeting
Published: 2021-04-14 (Crawled : 13:00) - globenewswire.com
IMAB | $1.805 0.28% 0.28% 110K twitter stocktwits trandingview |
Health Technology
| | O: 0.02% H: 14.14% C: 10.98%

presentation antibody
American Shared Hospital Services Announces Virtual-Only Annual Shareholder Meeting to be Held on June 25, 2021
Published: 2021-04-14 (Crawled : 12:15) - globenewswire.com
AMS | $3.02 0.84% -1.95% 15K twitter stocktwits trandingview |
Health Services
| | O: -0.4% H: 3.65% C: 2.44%


Inozyme Pharma Presents Data from Burden of Illness Study in Patients with ENPP1 Deficiency and ABCC6 Deficiency at the 2021 Annual Clinical Genetics Meeting
Published: 2021-04-14 (Crawled : 12:15) - biospace.com/
INZY | $4.4 0.0% 480K twitter stocktwits trandingview |
Health Technology
| | O: 2.06% H: 0.11% C: -3.04%

genetic
Rocket Pharmaceuticals Reports Positive Long-Term Clinical Data from RP-L201 Trial for the Treatment of Leukocyte Adhesion Deficiency-I at the Clinical Immunology Society 2021 Annual Meeting
Published: 2021-04-14 (Crawled : 12:00) - biospace.com/
RCKT 4 | $23.64 -0.13% -0.13% 920K twitter stocktwits trandingview |
Health Technology
| | O: 0.88% H: 7.34% C: 2.57%

treatment positive immunology trial
908 Devices to Report First Quarter Financial Results on May 13, 2021 and Host 2021 Annual Meeting of Stockholders on June 17, 2021
Published: 2021-04-14 (Crawled : 12:00) - globenewswire.com
MASS | $5.6 0.72% 0.71% 160K twitter stocktwits trandingview |
| | O: 0.32% H: 3.07% C: -2.53%

financial results results ev device
Inozyme Pharma Presents Data from Burden of Illness Study in Patients with ENPP1 Deficiency and ABCC6 Deficiency at the 2021 Annual Clinical Genetics Meeting of the American College of Medical Genetics and Genomics
Published: 2021-04-14 (Crawled : 12:00) - globenewswire.com
INZY | $4.4 0.0% 480K twitter stocktwits trandingview |
Health Technology
| | O: 2.06% H: 0.11% C: -3.04%

genetic genomic
Greenwich LifeSciences Announces Update of GP2 Phase III Clinical Trial Design at the 2021 AACR Annual Meeting
Published: 2021-04-14 (Crawled : 11:00) - biospace.com/
GLSI | $12.6 -4.11% -4.29% 29K twitter stocktwits trandingview |
Health Technology
| | O: 9.81% H: 3.2% C: -10.77%

trial designation
Gainers vs Losers
62% 38%

Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M twitter stocktwits trandingview |
Consumer Services

BOF | $1.99 70.09% 41.21% 110M twitter stocktwits trandingview |

ILAG | $0.51 6.03% 40.62% 1.7M twitter stocktwits trandingview |

LICN | $0.941 68.04% 40.49% 15M twitter stocktwits trandingview |

AMST | $3.31 65.5% 39.58% 70M twitter stocktwits trandingview |
Technology Services

MTC | $3.615 61.38% 38.04% 9.3M twitter stocktwits trandingview |
Technology Services

WIMI | $1.15 58.53% 36.92% 19M twitter stocktwits trandingview |
Technology Services

AIH | $0.45 12.5% 30.92% 320K twitter stocktwits trandingview |
Health Services

MULN | News | $3.78 38.46% 27.78% 13M twitter stocktwits trandingview |
Information

RILY | $29.86 37.48% 27.26% 12M twitter stocktwits trandingview |
Finance


Your saved searches
Save your searches and get alerts when important news are released.